Jane R Schwebke MD
Professor, Medicine, University of Alabama School of Medicine
Join to view full profile
619 19th St SBirmingham, AL 35233
Phone+1 205-934-6600
Dr. Schwebke is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
University of WashingtonFellowship, Infectious Disease, 1988 - 1989
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1984 - 1987- Northwestern University The Feinberg School of MedicineClass of 1984
Certifications & Licensure
IL State Medical License 1985 - 2029
AL State Medical License 1994 - 2025
FL State Medical License 2012 - 2016
WA State Medical License 1987 - 1991
American Board of Internal Medicine Internal Medicine
Clinical Trials
Publications & Presentations
PubMed
- 5 citationsVaginitis and risk of sexually transmitted infections: results of a multi-center U.S. clinical study using STI nucleic acid amplification testing.Jane R Schwebke, Paul Nyirjesy, Melissa Dsouza, Damon Getman
Journal of Clinical Microbiology. 2024-09-11 - Next generation sequencing to examine associations between vaginal washing and vaginal microbiota: A cohort study.Michelle C Sabo, Jennifer E Balkus, Barbra A Richardson, Sujatha Srinivasan, Joshua Kimani
International Journal of STD & AIDS. 2023-07-01 - 19 citationsVulvovaginal Candidiasis: A Review of the Evidence for the 2021 Centers for Disease Control and Prevention of Sexually Transmitted Infections Treatment Guidelines.Paul Nyirjesy, Carolyn Brookhart, Gweneth Lazenby, Jane Schwebke, Jack D Sobel
Clinical Infectious Diseases. 2022-04-13
Journal Articles
- Safety and Efficacy of a Novel Vaginal Anti-Infective, TOL-463, in the Treatment of Bacterial Vaginosis and Vulvovaginal Candidiasis: A Randomized, Single-Blind, Phase...Jeanne M Marrazzo, Julia C Dombrowski, Angela Pontius, Dwyn Dithmer, Jane Schwebke, Clinical Infectious Diseases
Press Mentions
- Engineered Phage Endolysin Is a Potential Solution for Recurrent Bacterial VaginosisOctober 28th, 2020
SCYNEXIS Announces Presentations at 2020 IDSOG Virtual Annual Meeting Highlighting Ibrexafungerp’s Potential for the Treatment of Vulvovaginal CandidiasisAugust 13th, 2020
Newly Published Research Shows That Hologic’s Molecular Assays for Diagnosing Vaginitis Are More Effective Than Traditional MethodsNovember 25th, 2019
Grant Support
- The UAB Infectious Diseases Training GrantNational Institute Of Allergy And Infectious Diseases2008–2011
- UAB Infectious Diseases Training GrantNational Institute Of Allergy And Infectious Diseases2005–2007
- Tinidazole For The Treatment Of Bacterial VaginosisNational Institute Of Allergy And Infectious Diseases2004–2007
- Therapy And Prevention For Bacterial VaginosisNational Institute Of Allergy And Infectious Diseases2002–2006
- Control Of Trichomoniasis -A Paradigm For STD ControlNational Institute Of Allergy And Infectious Diseases2002–2006
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
